- The trend backdrop is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
6598
TAI
Week ended 07 Aug 2026
Weekly Investor Report
Applied BioCode Corporation · Healthcare · Medical Devices
Latest close
28.80 TWD
-4.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 18.5% above the Trend Line and sits at 75.7% of its 52-week range. The latest completed week returned -4.3%, after a 26.0% four-week move. The latest news-sentiment score is 50/100.
Setup score
60
out of 100
Latest Close
28.80 TWD
7 Aug 2026
1W Return
-4.3%
latest completed week
4W Return
26.0%
short-term follow-through
12W Return
18.3%
quarterly tape
Trend Breadth
75.0%
39 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- Next-week expectancy is negative at 43.37% based on similar historical setup states.
- Recent volatility is running well above the one-year baseline.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-4.3%
Latest completed week; four-week move 26.0%.
Indicator stack
55/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.37%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 18.5% above the Trend Line and sits at 75.7% of its 52-week range. The latest completed week returned -4.3%, after a 26.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5712-week average 0.46
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.57Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 26.0% over four weeks, 18.3% over 12 weeks, and 44.7% over one year. The current trend has remained active for 4 consecutive weeks.
Performance by holding period
Active trend streak4 weeks
Active weeks in one year39
Trend breadth75.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.55Latest activity-pressure read.
Pressure change496.3%Four-week change in activity pressure.
Leadership-9.08Latest relative-leadership reading.
RS change70.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.7%Distance below the 52-week high.
13-week volatility6.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+21.0%Week of 17 Jul.
Worst week-6.4%Week of 27 Mar.
Latest week-4.3%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains7
Flat weeks0
Modest losses10
Sharp losses4
Recent vol6.7%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split26/25Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -2.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank1 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Medical Devices
4-week rank1 / 10
Group average-3.1%
Trend breadth30.0%
Trend30.0%active weekly trend signals
MD60.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape54/100
Trend, activity pressure, participation, and risk combine to a 54/100 tape read.
Indicator analysis54/100Latest 12-week confirmation: trend 11/12, activity pressure 7/12, relative leadership 0/12.
Activity pressure 0.57; No reversal markers Next-Week ExpectancyNegative 43.37%Next-week expectancy is negative with a 43.37% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 28.80 TWD | -4.3% | 24.31 TWD | 22.81 TWD | 1.55 | -9.08 | 3.1M | On |
| 31 Jul 2026 | 30.10 TWD | 8.7% | 24.09 TWD | 22.79 TWD | 1.06 | -3.06 | 5.0M | On |
| 24 Jul 2026 | 27.70 TWD | 0.2% | 23.82 TWD | 22.76 TWD | 0.56 | -12.26 | 4.6M | On |
| 17 Jul 2026 | 27.65 TWD | 21.0% | 23.61 TWD | 22.75 TWD | 0.02 | -10.96 | 4.9M | On |
| 10 Jul 2026 | 22.85 TWD | -0.9% | 23.39 TWD | 22.75 TWD | -0.39 | -31.17 | 267.2K | Off |
| 3 Jul 2026 | 23.05 TWD | 1.1% | 23.35 TWD | 22.77 TWD | -0.26 | -33.32 | 540.7K | On |
| 26 Jun 2026 | 22.80 TWD | -5.6% | 23.32 TWD | 22.80 TWD | -0.15 | -31.46 | 691.3K | On |
| 19 Jun 2026 | 24.15 TWD | -1.8% | 23.27 TWD | 22.83 TWD | 0.04 | -31.01 | 595.5K | On |
| 12 Jun 2026 | 24.60 TWD | 0.4% | 23.16 TWD | 22.85 TWD | 0.06 | -26.82 | 786.3K | On |
| 5 Jun 2026 | 24.50 TWD | -1.0% | 23.11 TWD | 22.87 TWD | 0.00 | -29.33 | 1.1M | On |
| 29 May 2026 | 24.75 TWD | 1.9% | 23.06 TWD | 22.89 TWD | -0.24 | -28.88 | 1.0M | On |
| 22 May 2026 | 24.30 TWD | -0.2% | 23.00 TWD | 22.90 TWD | -0.62 | -26.79 | 1.1M | On |
| 15 May 2026 | 24.35 TWD | 8.2% | 22.96 TWD | 22.92 TWD | -0.88 | -25.32 | 1.4M | Off |
| 8 May 2026 | 22.50 TWD | 4.9% | 22.92 TWD | 22.94 TWD | -1.04 | -32.26 | 655.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.